Patient Treatment Preferences and Decisional Needs for Heart Failure Medications

患者对心力衰竭药物的治疗偏好和决策需求

• 批准号: 456829
• 负责人: Turgeon Ricky D
• 金额: $ 7.29万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=456829&lang=en
• 关键词: Clinician Interviews; Decisional Needs Assessment; Discrete-Choice Experiment; Heart Failure; Medications; Patient Interviews; Patient Preferences And Values; Shared Decision-Making

Over 650,000 Canadians currently live with heart failure (HF). HF is a condition that develops when the heart is not strong enough to move blood around the body. HF causes symptoms like fatigue, breathlessness, and swelling that impact quality of life. Pe

目前，超过65万加拿大人患有心力衰竭（HF）。HF是一种当心脏不足以在身体周围移动血液时发生的疾病。HF会引起疲劳、呼吸困难和肿胀等症状，影响生活质量。PE